Torrent Pharmaceuticals posts Q1 FY 24 consolidated PAT at Rs. 378 Cr
Torrent Pharmaceuticals has reported total income of Rs. 2625 crores during the period ended June 30, 2023
Torrent Pharmaceuticals has reported total income of Rs. 2625 crores during the period ended June 30, 2023
The company has reported total income of Rs. 2481 crores during the period ended December 31, 2022
The scheme is subject to statutory and regulatory approvals as may be necessary.
The consideration includes Rs. 115 crore (on the date of signing) of cash and cash equivalents in the acquired business indicating an Enterprise Value of Rs. 1,885 crore
Torrent Pharmaceuticals has reported total income of Rs. 2377 crores during the period ended June 30, 2022.
The appraisal of the applications has been carried out based on the ranking methodology laid down in the operational guidelines of the Scheme
Torrent Pharmaceuticals Limited has reported consolidated financial results for the period ended September 30, 2021
Vikas Lifecare has already paid Rs. 25 million to the Advik bankers till date and the remaining amount shall also be paid within July 2021, making Advik a debt free company
The agreement will help ensure wider reach and access to patients in India
Subscribe To Our Newsletter & Stay Updated